Author

Alex Jia-Hong Lin

Observed name: Lin, Alex Jia-Hong

Institution: PharmaEssentia Corporation (Taiwan)

Observed institution: PharmaEssentia Corporation (Taiwan)

ORCID: 0000-0002-3511-2390

Observed ORCID: 0000-0002-3511-2390

OpenAlex ID: A5059713095

Association of JAK2V617F allele burden and clinical correlates in polycythemia vera: a systematic review and meta-analysis

2024 · Chih-Cheng Chen, Justin L. Chen, et al. · Annals of Hematology · 36

Current utilization of interferon alpha for the treatment of coronavirus disease 2019: A comprehensive review

2022 · Ling-Ying Lu, Po-Hao Feng, et al. · Cytokine & Growth Factor Reviews · 20

Real-world patient characteristics and treatment patterns of polycythemia vera in Taiwan between 2016 and 2017: a nationwide cross-sectional study

2023 · Tsung-Hsien Tsai, Lennex Hsueh-Lin Yu, et al. · Therapeutic Advances in Hematology · 11

Real-world characteristics and treatment patterns in essential thrombocythemia: a population-based cross-sectional study in Taiwan between 2020 and 2021

2025 · Ming-Sun Yu, Lennex Hsueh-Lin Yu, et al. · Therapeutic Advances in Hematology · 6

Five-year population-based study of essential thrombocythemia in Taiwan: Epidemiology, treatment patterns, and sex-based disparities

2026 · Alex Jia-Hong Lin, Cih-En Huang, et al. · Journal of the Formosan Medical Association · 1

Response to “Further considerations on sex-based disparities in essential thrombocythemia: Distribution, genotype, thrombotic risk, and survival”

2026 · Lennex Hsueh-Lin Yu, Alex Jia-Hong Lin, et al. · Journal of the Formosan Medical Association

Response to ‘comment on “Five-year population-based study of essential thrombocythemia in Taiwan: Epidemiology, treatment patterns, and sex-based disparities”’

2026 · Lennex Hsueh-Lin Yu, Alex Jia-Hong Lin, et al. · Journal of the Formosan Medical Association

Works count: 10

Citation count: 74

H-index: 4

I10-index: 3